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Gastrointestinal motility causes movement of food during digestion through contractions of the gut
smooth muscle. The enteric nervous system regulates these events, and Muller et al. now find that
its interaction with the immune system, in concert with gut microbiota, provides an additional layer
of regulation to this complex task.The gastrointestinal (GI) tract takes in
large food particles, digests them to
small-molecule components, absorbs the
resulting nutrients in specialized com-
partments along the length of the tract,
and eventually excretes the unwanted
byproducts. It also houses commensal
bacteria, which contribute to host meta-
bolism, immunoregulation, and pathogen
protection (Clemente et al., 2012). At the
heart of the GI tract’s function are its
intrinsic peristaltic movements, which
facilitate proper anterograde propulsion
of luminal contents. Richly innervated by
the enteric nervous system (ENS), the
gut senses food-induced stretch, as
well as changes in luminal chemistry.
This information is relayed to intrinsic
interneurons, causing ascending excit-
atory and descending inhibitory neuro-
transmission from the myenteric plexus,
resulting in a wave of smooth muscle
contraction behind the food bolus and
relaxation in front of it. These signals
act through pacemaker cells, called the
interstitial cells of Cajal (ICC), predomi-
nantly onto the inner circular muscle layer
of the muscularis externa (Kunze and
Furness, 1999). In this issue ofCell, Muller
et al. (2014) discover another layer of
complexity, revealing that, under homeo-
static conditions, proper gastrointestinal
motility relies on interactions between
the ENS and the microbiome, with a
tissue-resident population of muscularis
macrophages (MMs) at the crossroads.
MMs are one subset of a widely hetero-
geneous group of macrophages that
reside in tissue and contribute to normal
development, in addition to providing
trophic support and acting as immunesentinels (Wynn et al., 2013) (Figure 1).
Located in discrete sheets in the muscu-
laris externa, MM had previously been
implicated in the pathogenesis of pos-
toperative ileus, a temporary surgical
complication resulting in intestinal para-
lysis due to peristaltic failure (Mikkelsen,
2010; Matteoli et al., 2014). Although
MM were known to be in close apposi-
tion to the myenteric plexus and ICC,
nothing was known about the functional
role of MM under normal physiological
conditions or whether there was homeo-
static crosstalk between ENS neurons
and MM (Mikkelsen, 2010).
Muller et al. (2014) show that MM
are a uniform population of CX3CR1+
CD11cloMHCIIhi cells, exquisitely depen-
dent on the cytokine receptor CSF-1R,
as demonstrated by their almost com-
plete loss in CSFR1–/– mice. The authors
took advantage of this reliance by using
a single, low-dose intraperitoneal injec-
tion of a blocking anti-CSF-1R antibody
to specifically deplete 80% of MMs for
1 week, while leaving other GI resident
macrophage populations and stromal
cells intact. During MM depletion, mice
displayed accelerated gastric emptying
and reduced colonic emptying, and
in vitro experiments showed deregulated,
hyperreactive stretch-induced contrac-
tions of the muscularis externa, demon-
strating a homeostatic role for MMs in
the regulation of peristalsis. To discern
the molecular mechanism underlying
these effects, the authors analyzed
secreted, nonimmune transcripts of
MMs, finding a preferential expression of
bone morphogenetic protein 2 (BMP2)
(Figure 1), a soluble protein known toCellengage the BMP receptors I and II
(BMPRI and BMPRII). Given that BMPRI
and BMPRII had been implicated in
neuronal and smooth muscle develop-
ment, BMP2 was a likely candidate
for MM-mediated control of peristalsis.
Supporting this, the BMP2 inhibitor dor-
somorphin phenocopied MM depletion,
whereas recombinant BMP2 rescued the
phenotype.
As one hypothesis in the field proposed
that MMs engage in crosstalk with ICC
during ileus (Mikkelsen, 2010), Muller
et al. (2014) asked where BMP2 acts in
the steady-state GI tract. Surprisingly,
they found that BMPRII is expressed
in enteric neurons (Figure 1), but not in
ICC or enteric glia. Moreover, enteric
neurons exhibited constitutive activation
of SMAD1, SMAD5, and SMAD8, the
downstream signaling mediators of BMP
receptors, that was dependent on the
presence of MMs, suggesting that MMs
impact enteric neurons through secretion
of BMP2. Because MMs depended on
CSF-1R signaling, Muller et al. (2014)
next asked what the ligand is for CSF-1R
and its source. CSF-1R has two ligands,
CSF-1 and IL-34. Whereas multiple cell
types produce CSF-1, neuroepithelial
cells selectively produce IL-34. Remark-
ably, enteric neurons were found to pro-
duce CSF-1 (Figure 1), further suggesting
a crosstalk with MMs. Accordingly, mice
with an inactivating mutation of CSF-1
(Csf1op/op) show decreased SMAD acti-
vation and signs of GI dysmotility.
Many studies have established that the
intestinal microbiota educates mucosal
immune cells, including macrophages,
which, in turn, influence the ecology of158, July 17, 2014 ª2014 Elsevier Inc. 239
Figure 1. A Model for Neuroimmune Crosstalk Regulating GI Tract Peristalsis
The presence of bacterial products, including LPS, causes enteric neurons to produce CSF1, which binds
to the CSF-1R on CX3CR1+CD11cloMHCIIhi MMs and promotes their maintenance. MMs produce BMP2,
which binds to the BMP receptor, composed of BMPRI and BMPRII, the latter of which is expressed on
axons in the myenteric plexus, but not in ICC or enteric glia. Through a yet-undefined mechanism, BMP2
binding to enteric neurons regulates intestinal motility. Submucosal neural plexus and additional ICC
layers are excluded for simplicity.the microflora (Clemente et al., 2012).
Germ-free mice and mice treated with
antibiotics are also known to have GI dys-
motility. But could the intestinal micro-
biota influence the function of MMs
despite the distance between the intesti-
nal lumen and MMs? After treating mice
with antibiotics, Muller et al. (2014) found
decreased BMP2, decreased CSF1, and
decreased numbers of MMs in conjunc-
tion with GI dysmotility. In vitro culture
of enteric neurons with the bacterial pro-
duct LPS resulted in enhanced produc-
tion of CSF1, and supplementing the diet
of germ-free mice with LPS reconstituted
CSF1 and MM numbers and partially
improved GI transit time, though a fecal
transplant was necessary for complete
rescue. These results demonstrated that
the intestinal microbiota control GI peri-240 Cell 158, July 17, 2014 ª2014 Elsevier Instalsis at least in part through ENS-MM
crosstalk.
Although crosstalk between the ner-
vous and immune system during inflam-
mation has been well studied, particularly
in work pioneered by Kevin Tracey
and colleagues (Olofsson et al., 2012),
these findings advance our understand-
ing of the importance of bidirectional
neuroimmune communication for homeo-
static physiological functions. Immune
cells, particularly macrophages, produce
neurotropic factors such as BDNF (Par-
khurst et al., 2013), and the authors here
identify BMP2 as another neurotrophic
factor produced by macrophages. How-
ever, the question remains how BMP2
modulates ENS activity downstream of
SMAD activation. Does it regulate neuro-
transmitter production or release or alterc.electrophysiology and action potential
conduction? Finally, perhaps the most
important outcome of this study is the
identification of the intestinal microbiota
as a novel component in the neuroimmune
crosstalk, with MMs acting as intermedi-
aries between the microflora and the
ENS. This observation raises multiple
questions, such as howmicrobial compo-
nents reach MMs, whether LPS is the
main product that elicits ENS-MM cross-
talk, or whether multiple microbial prod-
ucts and sensors are implicated.
Like the heartbeat, GI motility is neces-
sary for life, as infants with Hirschsprung’s
disease who have congenital defects
in the distal ENS development and are
unable to pass excretory products die
in the first days of life without surgical
correction (Sasselli et al., 2012). Later in
life, functional bowel disorders including
irritable bowel syndrome (IBS) are pre-
valent and cause substantial morbidity
and heath care costs but are relatively
understudied (Talley, 2008). Better under-
standing of neuroimmune crosstalk
following the exciting results by Muller
et al. (2014) may open new avenues of
therapeutic intervention in disorders of
the GI motility.
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